NASDAQ · Financial Statements

DA32 Life Science Tech Acquisition Corp. (DALS) Financial Statements

$10.30 NASDAQ: DALS Market Cap $264.19M

DA32 Life Science Tech Acquisition Corp. most recently net profit of $1.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric2022
Revenue—
Operating Profit$-2.0M
Net Profit$1.0M
EPS$0.12
Op Margin—

Balance Sheet (USD)

Metric202120212022
Total Assets—$202.0M$204.0M
Total Liabilities—$6.0M$7.0M
Cash$0$0$0
Borrowings———

Cash Flow (USD)

Metric2022
Operating Cash Flow$-1.0M
Investing Cash Flow$0
Financing Cash Flow$0
Net Cash Flow$-1.0M
Free Cash Flow$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-0.38%
Quick Ratio1.00
Interest Coverage—
Return 1Y—
Return 3Y—
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Financial Services StocksLow P/E Financial Services StocksHigh Net Margin Financial Services StocksDividend Financial Services StocksLow Debt Financial Services StocksNasdaq High ROE StocksAll stock screens
DALS Overview DALS Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.